Artificial pancreas can prevent dangerously low blood sugar in people with T1D

August 27, 2020

WASHINGTON--A new artificial pancreas system can prevent hypoglycemia--episodes of dangerously low blood sugar--during and after heavy exercise in people with type 1 diabetes, according to a small study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Despite advances in treatment, blood sugar control in type 1 diabetes remains challenging. The artificial pancreas has the potential to automate much of the continuous work people with type 1 diabetes do to control their blood glucose levels, but exercise-related hypoglycemia is a major obstacle.

"Our new artificial pancreas system with a coordinated eating carbohydrate recommendation is both safe and effective in avoiding hypoglycemia and maintaining blood sugar control during and after heavy physical exercise in people with type 1 diabetes," said the study's corresponding author, Marga Giménez, M.D., Ph.D. of the Hospital Clínic de Barcelona in Barcelona, Spain. "Although exercise provides many health benefits, it has unpredictable effects on blood sugar control, making it difficult for people with type 1 diabetes to exercise daily. The artificial pancreas is emerging as the most promising treatment for managing type 1 diabetes, but exercise-related hypoglycemia remains a challenge."

The researchers tested their new artificial pancreas system on 10 adults with type 1 diabetes during an in-hospital clinical trial, measuring their blood sugar during and three hours after exercise. They found that the artificial pancreas system performed well and was safe during and after heavy exercise in people with type 1 diabetes in comparison with standard therapy.
-end-
Other authors include Clara Viñals of the Hospital Clínic de Barcelona; Aleix Beneyto of the University of Girona in Girona, Spain; Juan-Fernando Martín-SanJosé and Clara Furió-Novejarque of the Universitat Politècnica de València in València, Spain; Arthur Bertachi of the Federal University of Technology - Paraná (UTFPR) in Guarapuava, Brazil; Jorge Bondia of the Universitat Politècnica de València and the Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) in Madrid, Spain; Josep Vehi of the University of Girona and CIBERDEM; and Ignacio Conget and Marga Giménez of the Hospital Clínic de Barcelona, CIBERDEM and the Institut d'investigacions biomèdiques August Pi i Sunyer.

The study received funding from the Ministerio de Ciencia, Innovación y Universidades, the Conselho Nacional de Desenvolvimento Científico e Tecnológico, the Hospital Clínic de Barcelona and the Departament d'Universitats, Recerca i Societat de la Informació.

The manuscript, "Artificial Pancreas with Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes," was published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at?http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.